Arbutus Biopharma Corp Quarterly Liabilities and Equity in CAD from Q4 2010 to Q4 2013

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Arbutus Biopharma Corp quarterly Liabilities and Equity history and growth rate from Q4 2010 to Q4 2013.
  • Arbutus Biopharma Corp Liabilities and Equity for the quarter ending December 31, 2013 was CA$71.7M, a 36.4% increase year-over-year.
Liabilities and Equity, Quarterly (CAD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2013 71.7M +19.1M +36.4% Dec 31, 2013 10-K 2014-03-28
Q4 2012 52.6M +38.6M +276% Dec 31, 2012 10-K 2014-03-28
Q4 2011 14M -7.03M -33.4% Dec 31, 2011 20-F 2013-03-27
Q4 2010 21M Dec 31, 2010 20-F 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.